2D & 3D printing technologies in pharmaceutical manufacturing – Presented by Markus Dachtler, Gen-Plus

2D & 3D printing technologies in pharmaceutical manufacturing – Presented by Markus Dachtler, Gen-Plus at the 3D Medical Conference 2018,  which will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands.

Personalized medicine has gained growing interest over the last decade. Printed formulations can be individually and cost-effectively manufactured down to a batch size of one. Further advantages of printed dosage forms are e.g. combination of drugs and excipients which are not compatible with traditional manufacturing techniques enabling the production of polypills with tailor-made release characteristics. Drug printing can be also used for cost-effective dose-finding studies. The presentation gives an overview of 2D & 3D drug printing technologies and recent examples of drug printing in pharmaceutical manufacturing.

About Markus Dachtler
Dr. Markus Dachtler (MBA, PMP)  studied chemistry and is working for more than 12 years in pharmaceutical industry. In 2015 he acquired Gen-Plus in Munich. Gen-Plus is a high-tech R&D lab, developing hard-to-make formulations of solid/semi-solid dosage forms as well as patches (TTS) and thin films for many customers. This includes also e.g. high potent developments, narcotics, and abuse deterrent formulations from the idea phase until IMP production for clinical trials I/II under GMP. Novel technologies include 2D/3D drug printing and e-drug delivery systems. Dr. Dachtler gives regular lectures, has authored more than 20 publications in international journals and also holds patents. In his scientific career he got several innovation awards and the Richard R. Ernst Prize in 1998.

About Gen-Plus 
Gen-Plus is located in Munich and was founded in 1999 as a R&D-focused pharmaceutical company dealing with newest innovations in the field of formulation development and pharma technology. In 2015 the company was acquired by Dr. Markus Dachtler. The high-tech CRDO is working for many pharmaceutical companies and serves solutions for hard-to-make formulations (NCE, NTE, generic value added, OTC). Gen-Plus offers developments (solid, semi-solids, TTS, ODF) from idea phase to IMP production of clinical trials I/II under GMP conditions as well as newest pharma technology, e.g. 2D/3D drug printing

3D Medical Printing ConferenceAbout 3D Medical Conference
On January 30-31, 2018, MECC Maastricht, The Netherlands, will host a two-day event focused on 3D Medical Printing. Each day has different topics.

Day 1, Jan 30:

Day 2, Jan 31:

The audience, a mix of academics, medical professionals, business, technology, regulation and creatives, will get an excellent overview and insight in the medical tech developments from different perspectives.

Combination tickets are available and can be purchased on any of the conference websites.

Leave a Reply

Your email address will not be published.